St Vincent’s Hospital, Melbourne has reached the significant landmark of 100 microsurgical procedures using the cutting-edge Symani Robotic Surgical System, developed by surgical robotics company MMI (Medical Micro Instruments)

In recognition of Lung Health Awareness Month, we spoke with Victorian Interventional Pulmonologists Dr Nick Wilsmore and Dr Barton Jennings about their journey with robotic bronchoscopy.

Sydney Adventist Hospital has taken robotic-assisted surgery from installation to action, performing Australia’s first procedure using the da Vinci 5 robotic-assisted surgical system.

Epworth Freemasons has secured a national first, becoming the first hospital in Australia to install the da Vinci 5 robotic-assisted surgical system, setting a new benchmark for surgical innovation.

Device Technologies has been informed by Intuitive Surgical Sarl (Intuitive) of a cybersecurity incident involving unauthorised access to information within one of Intuitive’s internal IT business applications following a targeted phishing attack.

Device Technologies has announced the official inclusion of the Bentley BeFlared Stent Graft System, on the Australian Register of Therapeutic Goods (ARTG) (ARTG 523842), a major milestone in the treatment of complex aortic aneurysms.

St Vincent’s Private Hospital Sydney has become the first medical institution in NSW to install and implement the da Vinci SP*, the latest in robotic surgery technology, in order to improve patient outcomes and support surgical professionals.

Device Technologies has announced the official inclusion of Intuitive’s most advanced and integrated robotic-assisted surgical system, da Vinci 5*, on the Australian Register of Therapeutic Goods (ARTG) (ARTG 97348), marking a major leap forward in the evolution of minimally invasive surgery.

Device Technologies has announced the official inclusion of Route 92 Medical’s pioneering FreeClimb® system on the Australian Register of Therapeutic Goods (ARTG) (ARTG 515885, 516066 and 516067), making the innovative neurovascular intervention technology widely accessible across the country.

In today’s fast-paced healthcare environment, efficiency and accessibility are crucial for clinical teams, particularly in Gastroenterology. As a rapidly expanding specialty within the Australian and New Zealand healthcare systems, teams consistently experience high demand for gastroenterology care, with specialists, nurses, and allied health teams managing substantial patient volumes each day. At Device Technologies, our Gastroenterology team understands this best; each moment made more efficient is more time spent with patients, helping improve their outcomes.

Device Technologies has been awarded the 2025 Kerrin Rennie Award for excellence in medical technology.

Japan Lifeline Co. Ltd (JLL), a leading Japanese medical device company specialising in cardiology and cardiovascular surgery fields, has taken a significant step in appointing Device Technologies as their exclusive distributor in Australia and New Zealand, as they expand their presence into one of the region’s most significant healthcare markets.